Global Flow Diversion Aneurysm Treatment Market Analysis & Forecasts 2018-2022, With an Expected CAGR of 14% - ResearchAndMarkets.com

August 7, 2018

DUBLIN--(BUSINESS WIRE)--Aug 7, 2018--The “Global Flow Diversion Aneurysm Treatment Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The analysts forecast the Global Flow Diversion Aneurysm Treatment Market to grow at a CAGR of 14% during the period 2018-2022.

Flow diversion aneurysm treatment consists of the use of endovascular devices such as flow-diverting stents (FDS) and intrasaccular flow disruption devices. These devices are used in the treatment of intracranial aneurysms (IAs).

The report covers the present scenario and the growth prospects of the flow diversion aneurysm treatment market. To calculate the market size, the report considers the revenue generated from the sales of products such as flow-diverting stents (FDS) and intrasaccular flow disruption devices.

The increasing R&D focus will be a key trend driving the market growth. Several manufacturers of neuroendovascular treatment devices are investing in R&D, owing to the increasing acceptance of flow diversion practices in clinical practices. Several companies are also conducting clinical trials to test the efficacy of their flow diversion devices.

The increasing prevalence of IAs and associated risk factors will drive the market growth. The prevalence of IAs is increasing globally and significant amount of individuals die every year due to ruptured brain aneurysms. With the increased average life expectancy increasing the aging population, the aged population globally segment are highly susceptible to acquiring IAs.

The report states that the lack of awareness and access to flow diversion procedures in emerging countries will impact the market growth. Developing countries witness a significant lack of awareness about flow diversion procedures among clinicians and the general population. Also, several regions are understaffed of skilled neurosurgeons and neurologists capable of performing flow diversion procedures.

Companies Mentioned

Acandis Medtronic Phenox Stryker TERUMO CORPORATION

Key Topics Covered:

01. Executive Summary

02. Scope Of The Report

03. Research Methodology

04. Market Landscape

05. Market Sizing

06. Five Forces Analysis

07. Market Segmentation By Product

08. Customer Landscape

09. Regional Landscape

10. Decision Framework

11. Drivers And Challenges

12. Market Trends

13. Vendor Landscape

14. Vendor Analysis

15. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/kjrj7h/global_flow?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180807005404/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/07/2018 06:54 AM/DISC: 08/07/2018 06:54 AM


Update hourly